Prevalence of autoantibody responses in acute coronavirus disease 2019 (COVID-19)

The results suggest that acute COVID-19 is not associated with a high prevalence of clinically significant autoantibody responses of the type usually associated with autoimmune rheumatic disease, and strongly reactive antibodies to nuclear antigens are identified only in patients with a prior history of autoimmune disease.